Stocklytics Platform
Asset logo for symbol MDGL
Madrigal Pharmaceuticals
MDGL57
$276.34arrow_drop_up0.80%$2.21
High Growth
Asset logo for symbol MDGL
MDGL57

$276.34

arrow_drop_up0.80%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Madrigal Pharmaceuticals (MDGL) Stocklytics Forecast

According to the stock price prediction for Madrigal Pharmaceuticals Inc (MDGL), analysts forecast a positive future for the company. With its innovative drug pipeline and promising clinical trial results, MDGL is expected to achieve significant growth in the coming years. The AI-powered prediction models also suggest a bullish trend for MDGL, indicating potential gains for investors. Machine learning algorithms have analyzed various factors such as historical data, market trends, and company performance to generate accurate forecasts for MDGL.
Based on the latest price target estimates, analysts anticipate a substantial increase in MDGL's stock value by 2023. The projected price target indicates a positive outlook for the company, reflecting optimistic expectations from the market. Investors should consider these expert recommendations and price targets before making investment decisions regarding MDGL. It is worth noting that the analyst ratings for MDGL have also been positive, further adding to the potential attractiveness of the stock. With the combination of favorable forecasts, price targets, and analyst ratings, MDGL appears to be a good buy for investors seeking growth opportunities.
add Madrigal Pharmaceuticals  to watchlist

Keep an eye on Madrigal Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Madrigal Pharmaceuticals (MDGL) stock?

Analysts have set a target price of $327.41 for Madrigal Pharmaceuticals (MDGL), based on forecasts from 29 analysts. The predicted price range extends from a high of $425 to a low of $150. This represents a potential increase of up to 53.8% and a decrease of -45.72% from the current price of $276.34. These forecasts are as of 2023 Sep 12.
help

What are the analyst ratings for Madrigal Pharmaceuticals (MDGL) stock?

The analyst ratings for Madrigal Pharmaceuticals (MDGL) are distributed as follows: 13 analysts recommend buying, 2 have a neutral stance, and 1 suggest selling. The prevailing sentiment among the total of 16 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Madrigal Pharmaceuticals .
help

What is the AI price prediction for Madrigal Pharmaceuticals (MDGL) stock?

At present, there is no AI or machine-learning-based price prediction available for Madrigal Pharmaceuticals (MDGL) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level